Thursday, 31 August 2017 - 15:27
Navesta Pharmaceuticals inaugurates Rs. 1.4bn manufacturing facility in Horana


Navesta Pharmaceuticals has inaugurated Sri Lanka’s first sterile pharmaceutical manufacturing plant in Horana.

Navesta Pharmaceuticals is Sri Lanka’s first European Union Good Manufacturing Practices and Pharmaceutical Inspection Co-Operation Scheme, compliant facility which will enable the Company to export their products to most global markets that accepts these accreditations.

Additionally, the facility is also equipped with the Country’s first EU-GMP compliant A and B Grade Microbiology laboratory, capable of carrying out comprehensive, advanced in-house testing methodologies. 

Navesta Pharmaceuticals will primarily meet the local demand of 12 products in the Penicillin category (antibiotic drugs that are a part of the Beta Lactam group of medicines) dry powder injectable that were previously imported to the Country.

With the setting up of this 1.4 billion rupee facility, over 100 direct employment opportunities were created to include local graduates from chemistry, engineering, finance and pharmaceutical studies, while over 500 indirect employment opportunities were created through local industries and ancillary services.  

Chairman of Navesta Pharmaceuticals, Sanjaya Jayaratne speaking at the opening ceremony said, “We have and will continue to generate numerous employment opportunities for Sri Lankans who specialize in pharmaceutical fields such as Biochemistry, Pharmacology, Chemistry, Pharmacy and Engineering as well as Sri Lankans who are interested in developing this new industry further".

President Maithripala Sirisena was the chief guest at the opening ceremony and Health Minister, Dr. Rajitha Senaratne also attended.

Make a Comment
Make a Comment